Microbiología y parasitología
Especialidad
Emilia
Cercenado Mansilla
Publikationen, an denen er mitarbeitet Emilia Cercenado Mansilla (29)
2024
-
Epidemiological and clinical characterization of community, healthcare-associated and nosocomial colonization and infection due to carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Spain
Infection
-
Evolution of invasive pneumococcal disease by serotype 3 in adults: a Spanish three-decade retrospective study
The Lancet Regional Health - Europe, Vol. 41
2023
-
A New Integrative and Mobilizable Element Is a Major Contributor to Tetracycline Resistance in Streptococcus dysgalactiae subsp. equisimilis
Antibiotics, Vol. 12, Núm. 3
-
Activity of imipenem/relebactam against Enterobacterales and Pseudomonas aeruginosa in Spain. SMART 2016-2020
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 36, Núm. 3, pp. 302-309
-
Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis
The Lancet Regional Health - Europe, Vol. 34
-
Spanish Antibiogram Committee (COESANT) recommendations for cumulative antibiogram reports
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 7, pp. 430-435
2022
-
Genomic features of predominant non-PCV13 serotypes responsible for adult invasive pneumococcal disease in Spain
The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 9, pp. 2389-2398
2021
-
Penicillin susceptibility among invasive MSSA infections: A multicentre study in 16 Spanish hospitals
Journal of Antimicrobial Chemotherapy, Vol. 76, Núm. 10, pp. 2519-2527
-
Predicting Pseudomonas aeruginosa susceptibility phenotypes from whole genome sequence resistome analysis
Clinical Microbiology and Infection, Vol. 27, Núm. 11, pp. 1631-1637
-
Prevalence and Genetic Characteristics of Staphylococcus aureus CC398 Isolates From Invasive Infections in Spanish Hospitals, Focusing on the Livestock-Independent CC398-MSSA Clade
Frontiers in Microbiology, Vol. 12
2020
-
Emerging non-13-valent pneumococcal conjugate vaccine (PCV13) serotypes causing adult invasive pneumococcal disease in the late-PCV13 period in Spain
Clinical Microbiology and Infection, Vol. 26, Núm. 6, pp. 753-759
-
From CLSI to EUCAST, a necessary step in Spanish laboratories
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 2, pp. 79-83
-
Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 4, pp. 182-187
-
Two multi-fragment recombination events resulted in the β-lactam-resistant serotype 11A-ST6521 related to Spain9V-ST156 pneumococcal clone spreading in south-western Europe, 2008 to 2016
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 25, Núm. 16
2017
-
Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in Spain
PLoS ONE, Vol. 12, Núm. 4
-
Etestw versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: Results from PREMIUM, a European multicentre study
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 2, pp. 431-436
2016
-
Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain
Journal of Infection, Vol. 72, Núm. 2, pp. 152-160
2013
-
Epidemiological and clinical complexity of amoxicillin-clavulanate- resistant Escherichia coli
Journal of Clinical Microbiology, Vol. 51, Núm. 7, pp. 2414-2417
2012
-
Spanish multicenter study of the epidemiology and mechanisms of amoxicillin-clavulanate resistance in Escherichia coli
Antimicrobial Agents and Chemotherapy, Vol. 56, Núm. 7, pp. 3576-3581
2010
-
Antimicrobial resistance among respiratory pathogens in Spain: Latest data and changes over 11 years (1996-1997 to 2006-2007)
Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 7, pp. 2953-2959